The Wolcan, a medical technology that has been in development for many years, has been developed by the German government’s research institute, the Technische Universität München.
The technology, which is designed to treat heart disease, stroke, and other conditions, can be used in hospitals, universities and public health centers.
The Wolcoins new technology, the WolCOVER, can detect the heart rhythm in a patient, then stop the heart from beating until the rhythm is restored.
The device is being developed by a consortium of German companies, including Wolca, and the University of Wolces research institute.
WolCen has worked on the technology for years, and has patented its technology.
The company is also working with the University College London to make the technology available to the public.
The German government said in a press release on Thursday that it expects the WoloCen device to be available in hospitals within the next two years.
The WoloCOVER was shown off in a presentation in September at the World Congress of Technology and Design in Berlin.
The device was unveiled at the WOLCOVER’s presentation in Berlin, and a prototype was made available to WOLCen representatives on March 13.
WOLCoens technology was demonstrated during a WOLCAFE (World Congress of Civil and Environmental Engineering) in Berlin in September.